Why Pharmacists Need to Change Their Attitude


The opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.

There has been plenty of discussion regarding how pharmacists can curb the opioid epidemic, but one often-overlooked factor needs to be addressed: We need to make a fundamental shift in our attitude towards patients who are being affected by this crisis.

The CDC estimates that there were over 17,000 prescription opioid related deaths in the country-the equivalent of nearly 47 deaths per day-in 2016 alone, the most recent data available. The 2017 statistics are likely to be higher. In view of these numbers, our patients who have an opioid use disorder need to be viewed as a victim, not as a faulty individual.

Changing an Attitude

When consulting our patients with whom we suspect an opioid use disorder, we need to understand that they commonly want these medications to just feel “normal,” not get high or to sell. The patient should not be made to feel that they are doing something bad or are just “drug addicts.” Data from

National Survey on Drug Use and Health

(NSDUH) in 2016 found that 63.6% of those who developed an opioid usage disorder used the opioid to relieve pain, not for recreational use.

Related article: Four Ways Pharmacists Are Fighting Opioid Abuse

This epidemic is not the result of a character flaw, but often a result of those suffering from a drug use disorder caused by over-marketing by pharmaceutical companies, as well as over prescribing and dispensing. As pharmacists, we must remember that this patient may be in actual physical pain or is in fear of painful withdrawal symptoms. If a patient suspects that a pharmacist sees them as flawed in some way, they may turn away without accepting help. Consulting with this is mind leads to a more thoughtful conversation that can build a relationship.

Talking with Patients

No matter how difficult it is to start this conversation, it is essential that we convey our genuine concern for the patient. The following are possible examples of initiating the conversation:

  • “I would like to work with you to maximize your safety and wellbeing.”

  • “Are these medications helping to control your pain?”

  • “Are you experiencing any side effects from these medications?”

  • “Taking opioids over a long period of time can cause an accumulation in your body that can lead to an adverse reaction in the future.”

  • “My concern is that I do not want you or anyone else to experience any bad reactions.”

Avoid the word “overdose.” Patients may begin to tune out the conversation believing that “overdose” is meant for drug abusers-not themselves, who are taking medications as instructed.

Additional Safeguards

It is important to engage the prescribing physician. This will help you stay on the same page in understanding the patient’s unique situation. Prescribing naloxone is one example. The CDC recommends prescribing naloxone for patients on a dose of over 50 MME/day, and studies have shown that naloxone co-prescribed with opioid prescriptions has deterred patients from overusing their opioid medications.

Another safeguard is to recommend locking up opioid medications at home and to properly dispose of unneeded medications. The NSDUH showed that 40.6 of adults who misuse opioids obtained them from friends or family members. By securely storing and disposing of these dangerous medications, one source of potential abuse can be eliminated.

Related article: Drug Shortages Remain Major Concern for Hospital Pharmacists

An appropriate perspective with discussions that presents all options of treatment, including naloxone, possible drug interactions, responsible storage, and proper disposal, will enable us pharmacists to be able to curb the opioid epidemic.

Joseph L Lee is a 2019 PharmD/MPH candidate at Touro University California, Vallejo, CA. I would like to acknowledge Aglaia Panos, PharmD for her assistance in writing this article. Contact me at joseph.lee2@tu.edu

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.